Analystreport

Supernus Pharmaceuticals Inc (NASDAQ: SUPN) is now covered by analysts at Mizuho. They set a "buy" rating and a $61.00 price target on the stock.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com